Ultragenyx
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $173,000 | $214,000 | $136,000 | $207,000 |
Gross Profit | 141,000 | 180,000 | 106,000 | 178,000 |
EBITDA | -101,000 | -61,000 | -155,000 | -100,215 |
EBIT | -110,000 | -69,000 | -163,000 | -109,000 |
Net Income | -118,000 | -92,000 | -185,000 | -129,000 |
Net Change In Cash | 173,000 | 214,000 | 136,000 | 207,000 |
Free Cash Flow | -45,000 | -98,000 | -198,000 | -100,767 |
Cash | 150,000 | 125,000 | 175,000 | 434,000 |
Basic Shares | 102,100 | 101,900 | 100,600 | 99,900 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $673,000 | $560,230 | $434,249 | $363,329 |
Gross Profit | 564,000 | 483,502 | 389,040 | 335,009 |
EBITDA | -474,000 | -469,002 | -516,454 | -640,490 |
EBIT | -509,000 | -504,545 | -542,460 | -658,710 |
Net Income | -575,000 | -569,183 | -606,639 | -707,421 |
Net Change In Cash | 673,000 | 560,230 | 434,249 | 363,329 |
Cost of Revenue | -170,909 | |||
Free Cash Flow | -472,000 | -421,679 | -521,573 | -526,588 |
Cash | 434,000 | 173,729 | 213,584 | 132,944 |
Basic Shares | 98,600 | 90,538 | 73,543 | 69,914 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$1.16 |
2026-06-30 | -$0.90 |
2026-03-31 | -$1.54 |
2025-12-31 | -$1.29 |